Abstract
p53 exerts its tumor suppressor effects by activating genes involved in cell growth arrest and programmed cell death. The p53 target genes inducing growth arrest are well defined whereas those inducing apoptosis are not fully characterized. Proapoptotic activity of p53 was shown to involve several genes like Bax, Noxa and Puma, which may function in the release of cytochrome c from the mitochondria. Cytochrome c associates with Apaf-1 and caspase 9 to form the apoptosome. Genetic and cellular data indicate that Apaf-1 deficiency abrogates the apoptotic effect of p53 and substitutes for p53 loss in promoting tumor formation. Here we show that Apaf-1, the mammalian homologue of C. elegans CED4, is a direct target of p53 as demonstrated by gel shift analysis of the target site sequence in the presence of p53 and by Apaf-1 promoter-luciferase assays. We also show that the p53 activation of the Apaf-1 luciferase construct can be enhanced by the putative tumor suppressor gene product, Zac-1, a transcription factor that has previously been shown to inhibit cell proliferation. Furthermore, we demonstrate that Zac-1 is a possible direct target of p53 since the sequence upstream to the first coding exon of Zac-1 contains a p53 recognition site and the luciferase construct containing this region is activated by p53. These results suggests the existence of a tightly controlled self amplifying mechanism of transcriptional activation leading to apoptosis by p53.
Original language | English |
---|---|
Pages (from-to) | 1469-1476 |
Number of pages | 8 |
Journal | Oncogene |
Volume | 21 |
Issue number | 10 |
DOIs | |
State | Published - 28 Feb 2002 |
Externally published | Yes |
Bibliographical note
Funding Information:We thank Dr Moshe Oren for the baculovirus recombinant p53, the p53 cDNA constructs and pAb421 and for helpful discussion. We thank Dr M Stallcup for the Zac-1 construct and Dr X Wang for the Apaf-1 construct. This work was supported in part by the Arison Dorsman donation, the Yad Abraham Center for Cancer Diagnosis and Therapy and the Germany Israel Science Foundation (GIF). G Rechavi holds the Gregorio and Dora Shapiro Chair for Hematology Malignancies, Sackler School of Medicine Tel Aviv University. Part of this work was performed in partial fulfilment of the requirement of the Ph. D. degree of Galit Rozenfeld-Granot, Sackler Faculty of Medicine, Tel Aviv University.
Funding
We thank Dr Moshe Oren for the baculovirus recombinant p53, the p53 cDNA constructs and pAb421 and for helpful discussion. We thank Dr M Stallcup for the Zac-1 construct and Dr X Wang for the Apaf-1 construct. This work was supported in part by the Arison Dorsman donation, the Yad Abraham Center for Cancer Diagnosis and Therapy and the Germany Israel Science Foundation (GIF). G Rechavi holds the Gregorio and Dora Shapiro Chair for Hematology Malignancies, Sackler School of Medicine Tel Aviv University. Part of this work was performed in partial fulfilment of the requirement of the Ph. D. degree of Galit Rozenfeld-Granot, Sackler Faculty of Medicine, Tel Aviv University.
Funders | Funder number |
---|---|
Arison Dorsman donation | |
Germany Israel Science Foundation | |
Yad Abraham Center for Cancer Diagnosis and Therapy |
Keywords
- Apaf-1
- Apoptosis
- Promoter luciferase assay
- Zac-1 coactivation
- p53 target